ARGX:NASDAQ
argenx SE - ADR
US$ ९३०.५२
arrow_upward
+१.९३%(+१७.६५) 1D
US$ ९३१.३५
arrow_upward
+०.०९% (+०.८३)bedtimeAfter hours
Closed: अक्टोबर ६, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
US$ ९२२.३९
High
US$ ९४२.३५
Low
US$ ९०९.९४
Mkt. cap
५८.४५ अरब
Avg. vol.
२.५६ लाख
Volume
१२.००
P/E ratio
३५.३५
52-wk high
US$ १,०७२.७५
52-wk low
US$ ६६१.८५
EPS
US$ २६.३२
Beta
०.४५
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
Open
US$ ९२२.३९
High
US$ ९४२.३५
Low
US$ ९०९.९४
Mkt. cap
५८.४५ अरब
Avg. vol.
२.५६ लाख
Volume
१२.००
P/E ratio
३५.३५
52-wk high
US$ १,०७२.७५
52-wk low
US$ ६६१.८५
EPS
US$ २६.३२
Beta
०.४५
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
AD HOC NEWS
·
३ घण्टा पहिले
Goldman Sachs raises target for Argenx stock to EUR 982.00
Investing.com UK
·
१४ घण्टा पहिले
Halozyme expands argenx collaboration with two new targets By Investing.com
Stock Titan
·
१४ घण्टा पहिले
A drug-delivery partnership expands from six exclusive targets to eight.
AD HOC NEWS
·
१८ घण्टा पहिले
argenx stock: New VYVGART data span myasthenia gravis and CIDP
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR